Clinical Trial Update: Influence of Pregnenolone on Exposure Therapy in Obsessive-compulsive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether pregnenolone enhances exposure therapy for obsessive-compulsive disorder. The status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Pregnenolone (pregnenolone)

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Obsessive-compulsive Disorder (OCD) | Phase 2 | Status: UNKNOWN